NOVEMBER 2025 Research Alert

This month we added five new studies to the Best Practice Database, the Best Practices, LLC research repository. These studies focus on strengthening Rare Disease Medical Affairs performance and advancing patient-focused impact measurement. The first two studies explore how Rare Disease Medical Affairs teams demonstrate tactical and strategic value through indicators and outcomes, while the next three examine how leading organizations operationalize patient-centric strategies, connect Medical teams, and link Medical activities to measurable health outcomes.

The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.

	Download: Rare Disease Medical Affairs Impact Equation: Measuring Tactical Value Through Leading Indicators (5899) This benchmarking research shows how Rare Disease Medical teams track tactical value using MSL insights, evidence plans, and scientific exchange indicators.
	Download: Rare Disease Medical Affairs Impact Equation: Demonstrating Strategic Impact Through Outcomes and Data (5900) This research highlights how Rare Disease Medical teams use lagging indicators and data frameworks to link activities to strategic, real-world outcomes.
	Download: Patient-Focused Impact: Medical Strategies and Tactics That Drive Outcomes (5901) This Best Practices LLC study examines how Medical Affairs activates patient-centric strategies, integrates RWE/PROs, and uses omnichannel engagement to influence care.
	Download: Patient-Focused Impact: Linking Medical Activities to Outcomes (5902) This Best Practices LLC research outlines frameworks, metrics, and data sources for connecting Medical Affairs actions to measurable patient outcomes.
	Download: Patient-Focused Impact: Building Synergies Across Medical Teams (5903) This benchmarking study identifies gaps in Medical team connectivity and highlights practices that strengthen collaboration and improve patient outcomes.